← Back to catalogue

Återfuktande Nässpray Apofri

EUDAMED

Class IIa (EU MDR)

Ref 55.0396Model Moistening solution for nasal use (sodium hyaluronate and dexpanthenol)

by URSAPHARM Arzneimittel GmbH

Identity

Trade Name
Återfuktande Nässpray Apofri EUDAMED
Device Name
Moistening solution for nasal use based on sodium hyaluronate and dexpanthenol EUDAMED
Model / Reference
Moistening solution for nasal use (sodium hyaluronate and dexpanthenol) EUDAMED
55.0396 EUDAMED

Identifiers

Primary DI / UDI-DI
04031626002051 EUDAMED
Basic UDI-DI
4031626101365NL EUDAMED
EMDN Code
Q030103 NASAL IRRIGATION SOLUTIONS EUDAMED

Classification

Device Class
Class IIa EUDAMED
Market of Registration
Sweden EUDAMED

Clinical & Handling

Sterile

Yes

EUDAMED

Implantable

No

EUDAMED

Reusable

No

EUDAMED

Contains Latex

No

EUDAMED

Reprocessed

No

EUDAMED

CMR Substance

No

EUDAMED

Human-derived

No

EUDAMED

Human Tissues

No

EUDAMED

Animal Tissues

No

EUDAMED

Endocrine Disruptor

No

EUDAMED

Administering Medicine

No

EUDAMED

Measuring Function

No

EUDAMED

Incorporates Medicinal Product

No

EUDAMED

Återfuktande Nässpray Apofri by URSAPHARM Arzneimittel GmbH — Class IIa — MDR — listed in EUDAMED — regulatory data on deviCERTS

Authorization Coverage (European Union — 27 member states)

Regulatory Authorizations

European Union Active

CE/MDR

Is this your device? Claim it to add documentation and request validation.

Manufacturer

EUDAMED SRN
DE-MF-000007748

Sources (1)

  • EUDAMED a22c70fb-1d78-4cb7-8a4a-7a145cf6e094 61 fields · synced Jul 23, 2026